相关实验视频

Updated: Jan 13, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

活检形态测量作为预测初级脏病综合征治疗反应的指标

Bartholomeus T van den Berge^1,2, Jitske Jansen^3,4, Quinty Leusink¹

¹Department of Nephrology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands.

Kidney medicine

|January 9, 2026

概括

组织学特征,如细胞密度和皮质纤维化在脏活检可以预测治疗响应在初级瘤综合征 (PNS). 这些发现可能有助于估计患有异常性性综合征 (iNS) 和膜性性病 (MN) 的患者的蛋白尿结果.

科学领域:

腎臟病學 (nephrology) 是一種醫學專業.
脏病理学脏病理学
淋巴细胞疾病淋巴细胞疾病

背景情况:

原发性性综合征 (PNS) 的临床结果具有变化,因此对治疗反应的预测具有挑战性.
PNS的发病过程涉及细胞损伤和损失,这表明组织学标志物可能与预后相关.

研究的目的:

调查脏活检中的组织学参数,特别是与细胞枯竭相关的参数,是否可以预测PNS患者的治疗反应.
确定特定的活检标志物,预测在异形性性综合征 (iNS) 和膜性性病 (MN) 中的完全缓解 (CR).

主要方法:

对106名PNS患者 (最小变化疾病,焦点细分结核硬化,膜性脏病) 和9名对照者的回顾性队列研究.
对细胞和纤维化标志物染色的脏活检组织进行定量分析.
使用赔率比率和ROC-AUC进行统计分析,以确定CR和治疗反应的预测因素.

主要成果:

在iNS患者中,皮质纤维化 (ROC-AUC 0.79) 和 podocyte 密度是CR的显著预测因素.
在膜性病患者中,在免疫抑制和非免疫抑制治疗组 (ROC-AUC分别为0.71和0.80) 中,非硬化质密度预测了CR.
较低的血小板硬化和较高的非硬化血小板密度与MN中的CR有关.

结论:

组织学参数,包括细胞密度,淋巴细胞密度,淋巴细胞硬化和皮质纤维化,对于预测PNS的治疗反应非常有价值.
活检结果可以帮助估计iNS和MN患者的蛋白尿症结果.
这些发现支持使用定量活检分析用于综合征的个性化治疗策略.

关键词:

原发性脏病综合征的发生.葡萄糖样硬化症葡萄糖样硬化症葡萄细胞 (podocytes) 是一个细胞.预测者预测者预测者蛋白质尿症缓解缓解

更多相关视频

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis

Published on: June 18, 2020

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

相关概念视频

Nephrotic Syndrome II : Assessment and Medical Management

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...

Nephrotic Syndrome III : Nursing Management

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...